• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks

    Savaria Announces Preliminary Q4 2015 Results

    Vivien Diniz
    Jan. 20, 2016 09:03AM PST
    Medical Device Investing

    Savaria Corporation (TSX:SIS), announced partial results for its fourth quarter ended December 31, 2015.

    Savaria Corporation (TSX:SIS), announced partial results for its fourth quarter ended December 31, 2015.
    Included in the quarterly results:

    Quarter ended December 31, 2015

    • Revenue increase of 24%;
    • EBITDA increase of about 40%.

    Savaria saw a strong fourth quarter with sales of $26.6 million, representing growth of 24% over Q4 2014 and marking the company’s best-ever sales quarter in its history. We estimate an EBITDA of 16% of sales, an increase of about 40% over same period previous year, a result attributed to increased sales volume.

    Marcel Bourassa, President and Chief Executive Officer of Savaria stated:

    We are very pleased with the strong finish to our fiscal year. In spite of various market conditions, people age every day and we make products that help them maintain freedom and independence. The complete results for Q4 will be released with the year-end results after the close of the market on March 10th.

    Click here to view the full press release.
     

    The Conversation (0)

    Go Deeper

    AI Powered

    Sienna Biopharmaceuticals Reports First Quarter 2018 Financial Results

    Knight Therapeutics Reports Fourth Quarter and Year-End 2022 Results

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×